Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;24(sup1):132-133.
doi: 10.1080/13506129.2016.1272453.

Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?

Fabian Aus dem Siepen  1 , Selina Hein  1 , Ralf Bauer  1 , Hugo A Katus  1 , Arnt V Kristen  1
Affiliations

Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?

Fabian Aus dem Siepen et al. Amyloid. 2017 Mar.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey.
    Tini G, Cappelli F, Biagini E, Musumeci B, Merlo M, Crotti L, Cameli M, Di Bella G, Cipriani A, Marzo F, Guerra F, Forleo C, Gagliardi C, Zampieri M, Carigi S, Vianello PF, Mandoli GE, Ciliberti G, Lichelli L, Mariani D, Porcari A, Russo D, Licordari R, Ponziani A, Porto I, Perfetto F, Autore C, Rapezzi C, Sinagra G, Canepa M. Tini G, et al. ESC Heart Fail. 2021 Aug;8(4):3369-3374. doi: 10.1002/ehf2.13411. Epub 2021 May 14. ESC Heart Fail. 2021. PMID: 33988312 Free PMC article.
  • Hemodynamic testing to guide vasodilator therapy in cardiac amyloidosis.
    Rucker DM, Siddiqi OK, Pimentel DR, Luptak I. Rucker DM, et al. J Cardiol Cases. 2023 Jun 13;28(3):105-108. doi: 10.1016/j.jccase.2023.04.011. eCollection 2023 Sep. J Cardiol Cases. 2023. PMID: 37671260 Free PMC article.
  • Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis.
    Izumida T, Imamura T, Nakamura M, Kinugawa K. Izumida T, et al. J Cardiovasc Dev Dis. 2021 Dec 12;8(12):182. doi: 10.3390/jcdd8120182. J Cardiovasc Dev Dis. 2021. PMID: 34940536 Free PMC article.
  • Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement.
    Bonderman D, Pölzl G, Ablasser K, Agis H, Aschauer S, Auer-Grumbach M, Binder C, Dörler J, Duca F, Ebner C, Hacker M, Kain R, Kammerlander A, Koschutnik M, Kroiss AS, Mayr A, Nitsche C, Rainer PP, Reiter-Malmqvist S, Schneider M, Schwarz R, Verheyen N, Weber T, Zaruba MM, Badr Eslam R, Hülsmann M, Mascherbauer J. Bonderman D, et al. Wien Klin Wochenschr. 2020 Dec;132(23-24):742-761. doi: 10.1007/s00508-020-01781-z. Epub 2020 Dec 3. Wien Klin Wochenschr. 2020. PMID: 33270160 Free PMC article.
  • Conventional heart failure therapy in cardiac ATTR amyloidosis.
    Ioannou A, Massa P, Patel RK, Razvi Y, Porcari A, Rauf MU, Jiang A, Cabras G, Filisetti S, Bolhuis RE, Bandera F, Venneri L, Martinez-Naharro A, Law S, Kotecha T, Virsinskaite R, Knight DS, Emdin M, Petrie A, Lachmann H, Wechelakar A, Petrie M, Hughes A, Freemantle N, Hawkins PN, Whelan C, McMurray JJV, Gillmore JD, Fontana M. Ioannou A, et al. Eur Heart J. 2023 Aug 14;44(31):2893-2907. doi: 10.1093/eurheartj/ehad347. Eur Heart J. 2023. PMID: 37216684 Free PMC article.
See all "Cited by" articles

Substances

Supplementary concepts

LinkOut - more resources